COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,624 Articles (22,913 medRxiv, 8,711 bioRxiv)

Most recent first Previous |  Page 843: Articles 8421-8430  | Next

Identifiability of parameters in mathematical models of SARS-CoV-2 infections in humans
Ciupe, S. M., Tuncer, N.
10.1101/2022.04.26.22274345 — Posted: 2022-04-28
Evaluating diagnostic accuracies of Panbio™ COVID-19 rapid antigen test and RT-PCR for the detection of SARS-CoV-2 in Addis Ababa, Ethiopia using Bayesian Latent-Class Models (BLCM)
Sisay, A., Hartnack, S., Tiruneh, A., Desalegn, Y., Tesfaye, A., Desta, A. F.
10.1101/2022.04.25.22274285 — Posted: 2022-04-28
Exploring U.S. food system workers' intentions to work while ill during the early COVID-19 pandemic: a national survey analysis
Ceryes, C. A., Agnew, J., Wirtz, A. L., Barnett, D., Neff, R. A.
10.1101/2022.04.25.22274276 — Posted: 2022-04-28
Mobile Primary Healthcare for post-COVID Patients in Rural Areas: a Proof-of-Concept Study
Stallmach, A., Katzer, K., Besteher, B., Finke, K., Giszas, B., Gremme, Y., Abou-Hamdan, R., Lehmann-Pohl, K., Legen, M., Lewejohann, J. C., Machnik, M., Moshmosh Alsabbagh, M., Nardini, L., Puta, C., Stallmach, Z., Reuken, P.
10.1101/2022.04.26.22274329 — Posted: 2022-04-28
Observed strong pervasive positive selection in the N-terminal domain, receptor-binding domain and furin-cleavage sites of SARS-CoV-2 Spike protein sampled from Zimbabwean COVID-19 patients.
Kambarami, M. S., Manasa, J., Mushiri, T.
10.1101/2022.04.27.22274357 — Posted: 2022-04-28
Pilot study on the use of low molecular weight heparins in the prevention of thromboembolic disease during pregnancy and puerperium.
Anchustegui-Mendizabal, P., Anchustegui-Mendizabal, P., Arechabala-Palacios, L., Fernandez-Gonzalez, L., Garcia-Gil, C., Hernandez-Guijo, J. M., Martinez Perez, O.
10.1101/2022.04.26.22274264 — Posted: 2022-04-28
Faster SARS-CoV-2 sequence validation and annotation for GenBank using VADR
Nawrocki, E. P.
10.1101/2022.04.25.489427 — Posted: 2022-04-27
SARS-CoV-2 detection in wastewater as an early warning: the case of metropolitan area of the city of Buenos Aires (AMBA).
Barrio, A., Borro, V., Cicchino, M., Moron, A., Coronel, L., Vuolo, J., Mayon, P., Moroz, S., Maisa, P., Alcantara, S., Torras, M. A., Cervini Bohn, M., Arzeno, M., Godoy, C., Campillay, D., Filiel, N., Salas, A. C., Salvio, P.
10.1101/2022.04.23.22273730 — Posted: 2022-04-27
P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants
Kuzmina, A., Atari, N., Ottolenghi, A., Korovin, D., Cohen Lass, I., Rosental, B., Rosenberg, E., Mandelboim, M., Taube, R.
10.1101/2022.04.26.489630 — Posted: 2022-04-27
The impact of COVID-19 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis
Sabeena, S., Ravishankar, N., Robin, S., Sasidharan Pillai, S.
10.1101/2022.04.26.22274244 — Posted: 2022-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).